Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy

被引:25
|
作者
Kaminska, Marzena [1 ]
Kubiatowski, Tomasz [1 ]
Ciszewski, Tomasz [1 ]
Czarnocki, Krzysztof J. [1 ]
Makara-Studzinska, Marta [2 ]
Bojara, Iwona [3 ]
Staroslawska, Elzbieta [1 ]
机构
[1] St Johns Canc Ctr, Clin Oncol Ward, Lublin, Poland
[2] Med Univ Lublin, Dept Appl Psychol, Lublin, Poland
[3] Inst Rural Hlth Lublin, Dept Hlth Problems Ageing, PL-20090 Lublin, Poland
关键词
breast cancer; mastectomy; BCT; anxiety; depression; socio-demographic factors; MENTAL-HEALTH; DISPARITIES; SURVIVORS; LIFE;
D O I
10.5604/12321966.1141392
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Objective. Evaluation of the presence of symptoms of anxiety and depression in women treated for breast cancer who underwent surgical procedure using one of two alternative methods, either radical mastectomy or breast conserving treatment (BCT). Methods. A questionnaire survey involved 85 patients treated in a conservative way and 94 patients after breast amputation. Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI) and depression degree evaluation questionnaire were used in the study. The patients' responses were statistically analyzed. Results. Based on the HADS questionnaire, the total anxiety level in the group of women treated with BCT was 6.96 points, while in the group of patients who had undergone mastectomy the value was 7.8 points. The observed results were statistically significant. In the case of depression, the following values were found: patients after amputation had 8.04 scale value points, and those after BCT had 6.8 scale value points. The observed differences were statistically significant. Negative correlation was found between the level of anxiety and depression. The total level of depression evaluated using the Beck scale was 16.3 points in the BCT group, which means that they suffered from mild depression, while in the mastectomy group the level was 19.6 points, which corresponds to moderate depression. Conclusions. The level of anxiety and depression among women with breast cancer was influenced by the type of the applied surgical procedure and adjuvant chemotherapy. Demographic variables did not influence the level of anxiety and depression.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 50 条
  • [31] Depression and anxiety after adjuvant ovarian function suppression in premenopausal breast cancer patients
    Yi, H. W.
    Nam, S. J.
    Kim, S. W.
    Lee, J. E.
    Lee, S. K.
    Bae, S. Y.
    Park, S.
    Paik, H-J
    Ryu, J. M.
    CANCER RESEARCH, 2016, 76
  • [32] Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
    Pinder, Mary C.
    Duan, Zhigang
    Goodwin, James S.
    Hortobagyi, Gabriel N.
    Giordano, Sharon H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3808 - 3815
  • [33] Effect of breast conservation following neoadjuvant chemotherapy vs mastectomy with adjuvant chemotherapy in operable breast cancer
    Orozco, Javier
    Nelson, Daniel
    Chang, Shu-Ching
    Goldfarb, Melanie
    Holmes, Dennis
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 341 - 342
  • [34] Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: A comparative evaluation
    Ho, Simone S. M.
    So, Winnie K. W.
    Leung, Doris Y. P.
    Lai, Eve T. L.
    Chan, Carmen W. H.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2013, 17 (06) : 877 - 882
  • [35] Breast conservation after induction chemotherapy for locally advanced breast cancer
    Kling, KM
    Ostrzega, N
    Schmit, P
    AMERICAN SURGEON, 1997, 63 (10) : 861 - 864
  • [36] DEPRESSION AND ANXIETY IN WOMEN WITH BREAST CANCER AT THE FIRST ONCOLOGY CONSULTATION AFTER SURGERY
    Grazioli, L.
    Martinelli, V.
    Dionigi, F.
    Grasso, D.
    Sgarella, A.
    Ferrari, A.
    Riboni, G.
    Politi, P.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [37] DEPRESSION, ANXIETY AND SEXUAL DYSFUNCTION IN WOMEN WITH BREAST CANCER
    van Wessel, S.
    Maes, E.
    Braems, G.
    Makar, A.
    Jacobs, I.
    Van den Broecke, R.
    Tummers, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [38] CARDIOTOXICITY EVALUATION IN PATIENTS TREATED WITH A MITOXANTRONE COMBINATION AS ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    FOUNTZILAS, G
    AFTHONIDIS, D
    GELERIS, P
    SALEM, N
    KOTTAS, G
    HALKIDIS, C
    APOSTOLIDIS, P
    BEER, M
    TOURKANTONIS, A
    ANTICANCER RESEARCH, 1992, 12 (01) : 231 - 234
  • [39] Quality of life after adjuvant chemotherapy for breast cancer
    Jo Ann Broeckel
    Paul B. Jacobsen
    Lodovico Balducci
    John Horton
    Gary H. Lyman
    Breast Cancer Research and Treatment, 2000, 62 : 141 - 150
  • [40] Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
    Masuda, N.
    Lee, S. -J.
    Ohtani, S.
    Im, Y. -H.
    Lee, E. -S.
    Yokota, I.
    Kuroi, K.
    Im, S. -A.
    Park, B. -W.
    Kim, S. -B.
    Yanagita, Y.
    Ohno, S.
    Takao, S.
    Aogi, K.
    Iwata, H.
    Jeong, J.
    Kim, A.
    Park, K. -H.
    Sasano, H.
    Ohashi, Y.
    Toi, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22): : 2147 - 2159